TREATMENT
Clinical trials for TREATMENT explained in plain language.
Never miss a new study
Get alerted when new TREATMENT trials appear
Sign up with your email to follow new studies for TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made cancer vaccine shows promise in advanced tumors
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a personalized vaccine created from a patient's own immune cells (dendritic cells) that are trained to attack unique markers on their tumor. It is for people with advanced solid tumors who have not responded to standard treatments. The main goal is to check safet…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Fudan University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 17, 2026 12:04 UTC
-
New acid blocker may beat standard treatment for stomach bug
Disease control Recruiting nowThis study compares two types of acid-reducing medications—vonoprazan (a newer drug) and rabeprazole (a standard drug)—when used with bismuth and two antibiotics to treat H. pylori infection. About 320 adults with confirmed H. pylori who have not been treated before will receive …
Matched conditions: TREATMENT
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New drug combo aims to boost platelets in Hard-to-Treat ITP
Disease control Recruiting nowThis phase 2 trial tests whether combining rituximab with daratumumab can raise platelet counts in adults with immune thrombocytopenia (ITP) who have not responded to steroids. Twenty participants will receive one dose of rituximab and eight doses of daratumumab over eight weeks.…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Can switching meds help smokers who slip? new study aims to find out
Disease control Recruiting nowThis study tests whether changing treatments after an early relapse helps smokers quit. 544 smokers who want to quit will try nicotine patches, lozenges, varenicline, or e-cigarettes. If they slip in the first few weeks, they may switch to a different option. All visits are remot…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
New hope for ITP patients: drug combo aims to boost platelets
Disease control Recruiting nowThis study tests whether adding an anti-CD38 antibody to the standard drug rituximab works better than rituximab alone for adults with immune thrombocytopenia (ITP) whose platelet counts stayed low or came back after steroid treatment. About 160 participants will receive either t…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 22, 2026 12:06 UTC
-
Laser breakthrough? new trial aims to save sight in diabetic patients
Disease control Recruiting nowThis study tests a micropulse laser for diabetic macular edema, a condition causing vision loss in people with diabetes. Fifty participants with initial or stubborn swelling will receive the laser treatment. Researchers will measure changes in vision and retinal thickness to see …
Matched conditions: TREATMENT
Sponsor: The General Authority for Teaching Hospitals and Institutes • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
Promising Three-Drug cocktail targets tough leukemia mutation
Disease control Recruiting nowThis study tests a combination of three drugs—venetoclax, ivosidenib, and azacitidine—in adults with a specific genetic form of acute myeloid leukemia (IDH1-mutated AML). The goal is to see if this triple therapy can improve remission rates and survival compared to standard treat…
Matched conditions: TREATMENT
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Amniotic stem cells tested for rare, painful skin condition in kidney patients
Disease control Recruiting nowThis early-stage study tests whether stem cells from human amniotic fluid can help heal painful skin wounds (calciphylaxis) in people with chronic kidney disease. Nine participants will receive the stem cell treatment, and researchers will measure wound healing and pain levels. T…
Matched conditions: TREATMENT
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
New hope for kids with Hard-to-Treat blood disorder
Disease control Recruiting nowThis study tests an experimental drug called Anti-CD38 antibody in 60 children aged 6 and older who have immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The participants have not responded well to standard treatments.…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
New hope for ITP patients: antibody drug takes on standard therapy in head-to-head trial
Disease control Recruiting nowThis study compares two antibody drugs—daratumumab and rituximab—in 160 adults with immune thrombocytopenia (ITP) whose condition did not improve or came back after steroid treatment. The goal is to see which drug works better at raising platelet counts and reducing bleeding risk…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC
-
New glasses may slow kids' worsening eyesight
Disease control Recruiting nowThis study tests two types of special glasses (D.S.D.O. lenses) designed to slow the progression of nearsightedness (myopia) in children aged 6 to 14. About 120 children will wear the glasses daily for one year and have regular eye checkups. The goal is to see if these lenses can…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Ancient chinese medicine takes on early puberty: new trial tests herbs and acupuncture
Disease control Recruiting nowThis study tests whether a combination of Chinese herbs (Ziyin-Xiehuo) and intradermal acupuncture can help control idiopathic precocious puberty in girls. About 170 girls aged 7.5 or younger with early signs of puberty will receive either the treatment or a placebo. The goal is …
Matched conditions: TREATMENT
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New hope for kids with Hard-to-Treat ITP: daratumumab takes on rituximab
Disease control Recruiting nowThis study tests a new drug, daratumumab, against an older one, rituximab, in children aged 6 to 17 with immune thrombocytopenia (ITP) that didn't improve with steroids. ITP causes low platelets and easy bleeding. The goal is to see which drug works better at raising platelet cou…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New hope for young hodgkin patients: drug combo aims to cut radiation need
Disease control Recruiting nowThis study tests a new treatment for children, teens, and young adults (ages 2 to 34) newly diagnosed with classical Hodgkin lymphoma. The drug brentuximab vedotin replaces two older drugs to see if it can shrink tumors faster and more completely, so fewer patients need radiation…
Matched conditions: TREATMENT
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
Teens with concussions: could High-Dose exercise speed recovery?
Symptom relief Recruiting nowThis study tests whether doing more aerobic exercise than usual can help teens aged 13-18 recover faster from a concussion. Participants start within 14 days of injury and are assigned to either high-dose exercise (over 150 minutes per week at a safe intensity) or standard care. …
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 22, 2026 11:55 UTC
-
Teen concussion recovery: sleep program shows promise
Symptom relief Recruiting nowThis study tests a sleep health program for teens aged 10-19 who recently had a concussion. The goal is to see if better sleep helps symptoms go away faster and improves sleep quality, mood, and school engagement. Participants will be randomly assigned to the sleep program or sta…
Matched conditions: TREATMENT
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
Which surgery is better for uterine septum? new trial aims to find out
Knowledge-focused Recruiting nowThis study compares two surgical techniques for removing a uterine septum—a wall of tissue inside the uterus that can cause pregnancy complications. One method uses scissors without electricity, while the other uses a heated wire. Researchers will track surgery time, costs, and r…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 23, 2026 23:35 UTC
-
Can a nerve block cure your headache? new study investigates
Knowledge-focused Recruiting nowThis study aims to find out which patient factors influence how well a nerve block works for medication-overuse headache. Researchers will give 70 adults an ultrasound-guided injection and track their pain and medication use for one month. The goal is to better predict who will b…
Matched conditions: TREATMENT
Sponsor: Sultan 1. Murat State Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC